Teladoc Health, Inc. (TDOC) Stock Profile — Insider Trades & Financials

Revenue$606.9M

Net Income-$38.9M

EPS$-0.57

Market Cap$1.1B

Price Performance

Historical data including institutional events

Company Profile

Charles Divita

CEO & Executive Director

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

Employees: 2
Headquarters: NEW YORK, NY, United States
Website: www.teladoc.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Revenue$606.9M

Net Income-$38.9M

EPS$-0.57

Market Cap$1.1B

Price Performance

Historical data including institutional events

Company Profile

Charles Divita

CEO & Executive Director

Employees: 2
Headquarters: NEW YORK, NY, United States
Website: www.teladoc.com

Peer ComparisonRevenue ($B)

▾

Cross-Section Event Timeline

INSIDERS · CONGRESS · EARNINGS

INSIDER GRANT / AWARDMichael F. Grasher (Chief Financial Officer) GRANT / AWARD TDOCSep 1, 2026

INSIDER SELLCharles Divita III (CHIEF EXECUTIVE OFFICER) SELL TDOCSep 2, 2026

INSIDER SELLAdam C. Vandervoort (CHIEF LEGAL OFFICER, SECRETARY) SELL TDOCSep 2, 2026

INSIDER SELLJoseph Ronald Catapano (Chief Accounting Officer) SELL TDOCSep 2, 2026

INSIDER SELLKelly Bliss (President, U.S. Group Health) SELL TDOCSep 2, 2026

INSIDER SELLFernando M. Rodrigues (President of BetterHelp) SELL TDOCSep 2, 2026

INSIDER SELLCarlos Nueno (President, International) SELL TDOCSep 2, 2026

INSIDER SELLFernando M. Rodrigues (President of BetterHelp) SELL TDOCSep 3, 2026

INSIDER EXERCISE / CONVERSIONCharles Divita III (CHIEF EXECUTIVE OFFICER) EXERCISE / CONVERSION TDOCSep 10, 2026

INSIDER SELLCharles Divita III (CHIEF EXECUTIVE OFFICER) SELL TDOCSep 11, 2026

INSIDER EXERCISE / CONVERSIONJoseph Ronald Catapano (Chief Accounting Officer) EXERCISE / CONVERSION TDOCOct 1, 2026

INSIDER SELLJoseph Ronald Catapano (Chief Accounting Officer) SELL TDOCOct 2, 2026

⚡

Core Efficiency

ROE?

-2.97%

ROA?

-1.41%

D/E Ratio?

1.11

Op. Margin?

-6.11%

📊

Profitability Ratios

Net Margin?

-6.41%

Current Ratio?

0.83

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Oct 17, 2026 (in 4 days)

Quarterly Report (10-Q) — Based on filing pattern

Oct 17, 2026

Predicted10-Q

Jul 30, 2026

10-QQ2 202630d after period end

Apr 30, 2026

10-QQ1 202630d after period end

Feb 26, 2026

10-KQ4 20259d after period end

Oct 30, 2025

10-QQ3 20257d after period end

Jul 30, 2025

10-QQ2 20257d after period end

Data Freshness

Financial Data

2mo ago

Latest filing: 2026-07-30

SEC Metadata

2mo ago

Latest filing: 2026-07-30

Loading company sections...

Teladoc Health, Inc.

Price Performance

Company Profile

Teladoc Health, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades

Teladoc Health, Inc.

Price Performance

Company Profile

The morning brief, before the bell.

Teladoc Health, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades